Cannabis could have a role in treating obesity-related fatty liver disease, according to a Hebrew University project that has been awarded funding by a UK-Israeli startup.
The research focuses on cannabidiol, also known as CBD, a naturally occurring chemical found in marijuana plants.
It accounts for about 40% of the extract of the cannabis plant and is classed as a medicine in the UK and Israel.
“We know CBD is potentially able to elicit positive metabolic effects under fatty conditions such as an unbalanced diet,” said Dr Joseph Tam, from the university’s Obesity & Metabolism Laboratory unit.
Click here to read the complete article
Simon Griver ~ TheJC,com ~
